반응 #535244

ord-377a74b40b0e4f248bb0f7341cc81471

반응 방정식

Cc1ccc(F)cc1C(=O)O
5-fluoro-2-methylbenzoic acid
CN(C)C(On1nnc2cccnc21)=[N+](C)C.F[P-](F)(F)(F)(F)F
HATU
CCN(C(C)C)C(C)C
DIEA
CCCC[n+]1nc(C)sc1C.[I-]
3-butyl-2,5-dimethyl-1,3,4-thiadiazol-3-ium iodide
CCCCN1N=C(C)S/C1=C\C(=O)c1cc(F)ccc1C
title compound
CCCCN1N=C(C)S/C1=C\C(=O)c1cc(F)ccc1C
(2Z)-2-(3-butyl-5-methyl-1,3,4-thiadiazol-2(3H)-ylidene)-1-(5-fluoro-2-methylphenyl)ethanone

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    농축concentrated in vacuo
  2. 2
    기타purified by reverse phase HPLC

실험 절차

In a 20 mL vial 5-fluoro-2-methylbenzoic acid (0.9 mL of 0.2 M in DMA, 1.10 equiv) was added followed by the addition of HATU (76 mg in 0.7 mL of DMA, 0.2 mmol, 1.20 equiv.), DIEA (51 mg in 0.7 mL of DMA, 0.4 mmol, 2.40 equiv.), and finally 3-butyl-2,5-dimethyl-1,3,4-thiadiazol-3-ium iodide (49 mg in 0.7 mL of DMA, 0.17 mmol, 1 equiv.). The mixture was shaken overnight at room temperature and then concentrated in vacuo. The resulting residue was taken up in 1:1 DMSO/MeOH and purified by reverse phase HPLC using a method analogous to that described in Example 53 to provide the title compound. 1H NMR (500 MHz, DMSO-d6/D2O) δ ppm 0.90 (t, 3 H) 1.68-1.76 (m, 2 H) 2.34 (s, 3 H) 2.48 (s, 3 H) 4.16 (t, 2 H) 6.26 (s, 1 H) 7.10-7.16 (m, 1 H) 7.23-7.32 (m, 2 H); MS (ESI) m/z 307 (M+H)+.

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US08481574B2uspto-grants-2013_07